Dr Mary Jo DiMilia (MD) is on staff at the Mount Sinai Medical Center in New York, is the founder and former director of the Combined Internal Medicine and Paediatrics Residency Program and currently holds faculty positions as Clinical Assistant Professor of Medicine and Clinical Assistant Professor of Paediatrics at the Icahn School of Medicine at Mount Sinai.
Dr DiMilia is bringing new evidence-based, adjunctive treatment for cancer patients through the use of repurposed or off-label prescription medications combined with vitamins and supplements. Each patient’s protocol is comprehensive and personalised with scientific evidence to support its use. The repurposed prescription medications will make cancer more sensitive to radiation and chemotherapy, in addition to enhancing the metabolic approach to deprive cancer cells and increasing cancer cell apoptosis (death of cells).
Innovative healthcare incorporating vitamins, supplements and repurposed medications or “off-label drugs as adjunct treatment for cancer patients of all ages
We use cookies to improve your experience on our site. Learn more.
We use cookies to enhance your browsing experience and enable essential functions on our website. Some cookies are categorised as "Necessary" are automatically stored on your browser as they are crucial for the basic operation of the site - they can no be adjusted using these tools. Additionally, we use third-party cookies to help us analyse your usage of the website. These cookies are stored in your browser only with your prior consent. You have the option to enable or disable some or all of these cookies.